“Rho Kinase Inhibitors for Glaucoma and Optic Neuropathy Treatment: Enzyme Activity, Cell Effects, IOP-Lowering and Neuroprotection Perspectives” (2022) Open Access Journal of Ophthalmology, 7(1), pp. 1–23. doi:10.23880/oajo-16000233.